UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Leukemia, 2018-09, Vol.32 (9), p.1970-1983

2018

Volltextzugriff (PDF)

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Nature communications, 2022-06, Vol.13 (1), p.3296-3296, Article 3296

2022

Volltextzugriff (PDF)

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

Molecular cancer therapeutics, 2013-08, Vol.12 (8), p.1461-1470

2013

Volltextzugriff (PDF)

Co-evolution of tumor and immune cells during progression of multiple myeloma

Nature communications, 2021-05, Vol.12 (1), p.2559-2559, Article 2559

2021

Volltextzugriff (PDF)

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific reports, 2022-01, Vol.12 (1), p.30-30, Article 30

2022

Volltextzugriff (PDF)

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

Leukemia, 2022-06, Vol.36 (6), p.1625-1634

2022

Volltextzugriff (PDF)

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical cancer research, 2021-04, Vol.27 (7), p.1974-1986

2021

Volltextzugriff (PDF)

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8), p.1214-1233

2023

Volltextzugriff (PDF)

Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types

PloS one, 2015-05, Vol.10 (5), p.e0127828-e0127828

2015

Volltextzugriff (PDF)

The function of the conserved regulatory element within the second intron of the mammalian Csf1r locus

PloS one, 2013-01, Vol.8 (1), p.e54935

2013

Volltextzugriff (PDF)

Collaborative Control of Cell Cycle Progression by the RNA Exonuclease Dis3 and Ras Is Conserved Across Species

Genetics (Austin), 2016-06, Vol.203 (2), p.749-762

2016

Volltextzugriff (PDF)

RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (10), p.3897-3902

2008

Volltextzugriff (PDF)

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

Blood cancer journal (New York), 2018-03, Vol.8 (3), p.35-10, Article 35

2018

Volltextzugriff (PDF)

Anti-myeloma efficacy of BCMA CAR-iNKT is enhanced with a long-acting IL-7, rhIL7hyFc

Journal of bone oncology, 2024-04, Vol.45, p.100537, Article 100537

2024

Volltextzugriff (PDF)

c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations

Blood, 2005-10, Vol.106 (7), p.2452-2461

2005

Volltextzugriff (PDF)

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

Leukemia, 2021-08, Vol.35 (8), p.2346-2357

2021

Volltextzugriff (PDF)

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Journal of bone oncology, 2024-04, Vol.45, p.100553, Article 100553

2024

Volltextzugriff (PDF)

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Blood advances, 2023-10, Vol.7 (20), p.6009-6022

2023

Volltextzugriff (PDF)

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.29-40

2016

Volltextzugriff (PDF)

An Activated Receptor Tyrosine Kinase, TEL/PDGFβR, Cooperates with AML1/ETO to Induce Acute Myeloid Leukemia in Mice

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (16), p.9506-9511

2003

Volltextzugriff (PDF)

Traversing the bench to bedside journey for iNKT cell therapies

Frontiers in immunology, 2024-08, Vol.15, p.1436968

2024

Volltextzugriff (PDF)

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Journal of cellular and molecular medicine, 2022-02, Vol.26 (3), p.940-944

2022

Volltextzugriff (PDF)

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

European journal of nuclear medicine and molecular imaging, 2021-05, Vol.48 (5), p.1302-1311

2021

Volltextzugriff (PDF)

Strategies to Implement a Competency Assessment Verification Program

AORN journal, 2021-05, Vol.113 (5), p.455-463

2021

Volltextzugriff (PDF)

Targeting Normal Myelopoiesis Negatively Affects CAR T Cell Activity

Blood, 2023-11, Vol.142 (Supplement 1), p.2077-2077

2023

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(125)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

Co-evolution of tumor and immune cells during progression of multiple myeloma

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types

The function of the conserved regulatory element within the second intron of the mammalian Csf1r locus

Collaborative Control of Cell Cycle Progression by the RNA Exonuclease Dis3 and Ras Is Conserved Across Species

RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

Anti-myeloma efficacy of BCMA CAR-iNKT is enhanced with a long-acting IL-7, rhIL7hyFc

c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

An Activated Receptor Tyrosine Kinase, TEL/PDGFβR, Cooperates with AML1/ETO to Induce Acute Myeloid Leukemia in Mice

Traversing the bench to bedside journey for iNKT cell therapies

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

Strategies to Implement a Competency Assessment Verification Program

Targeting Normal Myelopoiesis Negatively Affects CAR T Cell Activity

Suchergebnisse filtern